Identifying risks in patients with uncomplicated type B aortic dissection
Risk stratification of uncomplicated type B aortic dissection using clinical and engineering analysis
This study is looking at patients with uncomplicated type B aortic dissection to find out who might need earlier treatment instead of just standard care, so they can get the best help possible.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10897983 on NIH RePORTER |
What this research studies
This research focuses on patients with uncomplicated type B aortic dissection, a serious condition where a tear in the aorta can lead to severe complications. The study aims to develop a risk stratification model that helps predict which patients may not respond well to standard medical treatment and may need earlier intervention. By analyzing clinical and anatomical data from a large patient database, the researchers hope to improve patient outcomes through better decision-making regarding treatment timing. This approach combines clinical assessments with advanced imaging techniques to enhance understanding of the condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with uncomplicated type B aortic dissection who are currently receiving optimal medical therapy.
Not a fit: Patients with complicated type B aortic dissection requiring immediate surgical intervention may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved survival rates and better long-term outcomes for patients with uncomplicated type B aortic dissection.
How similar studies have performed: Previous research has shown promise in using risk stratification models for other cardiovascular conditions, indicating potential success for this novel approach.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Leshnower, Bradley Graham — Emory University
- Study coordinator: Leshnower, Bradley Graham
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.